These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 36619616)

  • 21. The Achilles' heel of cancer: targeting tumors via lysosome-induced immunogenic cell death.
    Iulianna T; Kuldeep N; Eric F
    Cell Death Dis; 2022 May; 13(5):509. PubMed ID: 35637197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducing immunogenic cell death in immuno-oncological therapies.
    Ti D; Yan X; Wei J; Wu Z; Wang Y; Han W
    Chin J Cancer Res; 2022 Feb; 34(1):1-10. PubMed ID: 35355932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.
    Facchinetti F; Proto C; Minari R; Garassino M; Tiseo M
    Handb Exp Pharmacol; 2018; 249():63-89. PubMed ID: 28332047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
    Liu J; Liu Y
    Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
    Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
    Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
    BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Scope of Targeted Therapies in Lung Carcinoma.
    Sonkar A; Kumar P; Gautam A; Maity B; Saha S
    Mini Rev Med Chem; 2022; 22(4):629-639. PubMed ID: 34353252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
    Reis H; Metzenmacher M; Goetz M; Savvidou N; Darwiche K; Aigner C; Herold T; Eberhardt WE; Skiba C; Hense J; Virchow I; Westerwick D; Bogner S; Ting S; Kasper S; Stuschke M; Nensa F; Herrmann K; Hager T; Schmid KW; Schuler M; Wiesweg M
    Clin Lung Cancer; 2018 Jul; 19(4):e441-e463. PubMed ID: 29631966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic Cell Death-Based Cancer Vaccines.
    Jin MZ; Wang XP
    Front Immunol; 2021; 12():697964. PubMed ID: 34135914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer.
    Kuang X; Xiao J; Dai LX; Zhang LH; He BX
    Transl Cancer Res; 2019 Jun; 8(3):736-751. PubMed ID: 35116812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer.
    Roys A; Chang X; Liu Y; Xu X; Wu Y; Zuo D
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):679-688. PubMed ID: 31256210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.
    Chiaravalli M; Spring A; Agostini A; Piro G; Carbone C; Tortora G
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.
    Lin RA; Lin JK; Lin SY
    Kaohsiung J Med Sci; 2021 Jun; 37(6):448-458. PubMed ID: 33636043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
    Byeon S; Lee B; Park WY; Choi YL; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
    Clin Lung Cancer; 2020 May; 21(3):e182-e190. PubMed ID: 31839532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.
    Fois SS; Paliogiannis P; Zinellu A; Fois AG; Cossu A; Palmieri G
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New horizons for uncommon mutations in non-small cell lung cancer:
    Olmedo ME; Cervera R; Cabezon-Gutierrez L; Lage Y; Corral de la Fuente E; Gómez Rueda A; Mielgo-Rubio X; Trujillo JC; Couñago F
    World J Clin Oncol; 2022 Apr; 13(4):276-286. PubMed ID: 35582653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.